We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cullen/Frost (CFR) Reports Q2 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
For the quarter ended June 2023, Cullen/Frost Bankers (CFR - Free Report) reported revenue of $512.12 million, up 25.1% over the same period last year. EPS came in at $2.47, compared to $1.81 in the year-ago quarter.
The reported revenue represents a surprise of +1.05% over the Zacks Consensus Estimate of $506.78 million. With the consensus EPS estimate being $2.40, the EPS surprise was +2.92%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Cullen/Frost performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Interest Margin (FTE): 3.45% versus 3.47% estimated by seven analysts on average.
Net loan charge-offs to average loans: 0.22% compared to the 0.2% average estimate based on six analysts.
Total earning assets and average rate earned - Average balance: $45.93 billion versus $47.11 billion estimated by six analysts on average.
Total Non-Performing Loans/ Non-accrual loans: $67.78 million versus the three-analyst average estimate of $38.69 million.
Tier 1 Risk-based Capital Ratio: 13.92% versus the three-analyst average estimate of 13.93%.
Total Risk-based Capital Ratio: 15.39% compared to the 15.43% average estimate based on three analysts.
Leverage Ratio: 8.11% versus 7.86% estimated by two analysts on average.
Net Interest Income (FTE): $408.59 million compared to the $411.29 million average estimate based on seven analysts.
Total Non-Interest Income: $103.53 million versus $99.45 million estimated by seven analysts on average.
Net Interest Income: $385.27 million compared to the $383.11 million average estimate based on six analysts.
Other charges, commissions and fees: $12.09 million versus $11.71 million estimated by five analysts on average.
Trust and investment management fees: $39.39 million versus the five-analyst average estimate of $37.25 million.
Shares of Cullen/Frost have returned +11.6% over the past month versus the Zacks S&P 500 composite's +5.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cullen/Frost (CFR) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2023, Cullen/Frost Bankers (CFR - Free Report) reported revenue of $512.12 million, up 25.1% over the same period last year. EPS came in at $2.47, compared to $1.81 in the year-ago quarter.
The reported revenue represents a surprise of +1.05% over the Zacks Consensus Estimate of $506.78 million. With the consensus EPS estimate being $2.40, the EPS surprise was +2.92%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Cullen/Frost performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Interest Margin (FTE): 3.45% versus 3.47% estimated by seven analysts on average.
- Net loan charge-offs to average loans: 0.22% compared to the 0.2% average estimate based on six analysts.
- Total earning assets and average rate earned - Average balance: $45.93 billion versus $47.11 billion estimated by six analysts on average.
- Total Non-Performing Loans/ Non-accrual loans: $67.78 million versus the three-analyst average estimate of $38.69 million.
- Tier 1 Risk-based Capital Ratio: 13.92% versus the three-analyst average estimate of 13.93%.
- Total Risk-based Capital Ratio: 15.39% compared to the 15.43% average estimate based on three analysts.
- Leverage Ratio: 8.11% versus 7.86% estimated by two analysts on average.
- Net Interest Income (FTE): $408.59 million compared to the $411.29 million average estimate based on seven analysts.
- Total Non-Interest Income: $103.53 million versus $99.45 million estimated by seven analysts on average.
- Net Interest Income: $385.27 million compared to the $383.11 million average estimate based on six analysts.
- Other charges, commissions and fees: $12.09 million versus $11.71 million estimated by five analysts on average.
- Trust and investment management fees: $39.39 million versus the five-analyst average estimate of $37.25 million.
View all Key Company Metrics for Cullen/Frost here>>>Shares of Cullen/Frost have returned +11.6% over the past month versus the Zacks S&P 500 composite's +5.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.